Time to Surgery and Breast Cancer Survival in the United States. - Wikidata - wikimedia - TriplyDB

Time to Surgery and Breast Cancer Survival in the United States.

Time to Surgery and Breast Cancer Survival in the United States.

http://www.wikidata.org/entity/Q36678065

about

Tumor growth rate of invasive breast cancers during wait times for surgery assessed by ultrasonography Surgery of the primary tumor improves survival in women with stage IV breast cancer in Southwest China: A retrospective analysis.Factors that influence treatment delay in patients with colorectal cancer.Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.Hormone receptor status may impact the survival benefit of surgery in stage iv breast cancer: a population-based study.The influence of timing of radiation therapy following breast-conserving surgery on 10-year disease-free survival.Second opinions from urologists for prostate cancer: Who gets them, why, and their link to treatment.Preoperative clinical pathway of breast cancer patients: determinants of compliance with EUSOMA quality indicators.Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia.Access to Care in Vermont: Factors Linked With Time to Chemotherapy for Women With Breast Cancer-A Retrospective Cohort Study.Time to Treatment: Measuring Quality Breast Cancer Care.Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries.Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.What Do Patients Prefer? Understanding Patient Perspectives on Receiving a New Breast Cancer Diagnosis.Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach.Patterns of multidisciplinary care in the management of non-metastatic invasive breast cancer in the United States Medicare patient Time interval of neoadjuvant chemotherapy to surgery in breast cancer: how long is acceptable?Elevated expression of chemokine C-C ligand 2 in stroma is associated with recurrent basal-like breast cancers.Coordination of radiologic and clinical care reduces the wait time to breast cancer diagnosis.Optimal timing of delivery for women with breast cancer, according to cancer stage and hormone status: a decision-analytic model.Factors influencing time to seeking medical advice and onset of treatment in women who are diagnosed with breast cancer in Serbia.Starting hormone therapy immediately after histological diagnosis of breast cancer.Modelling breast cancer tumour growth for a stable disease population.Omission of radiotherapy after breast conservation surgery in the postneoadjuvant setting.Determination of the impact of melanoma surgical timing on survival using the National Cancer Database.Preoperative Panel Testing for Hereditary Cancer Syndromes Does Not Significantly Impact Time to Surgery for Newly Diagnosed Breast Cancer Patients Compared with BRCA1/2 Testing.Physician peer group characteristics and timeliness of breast cancer surgery.Breast Cancer Diagnosis and Treatment After High-Deductible Insurance Enrollment.The National Surgical Quality Improvement Program 30-Day Challenge: Microsurgical Breast Reconstruction Outcomes Reporting Reliability.Impact of Insurance Coverage on Outcomes in Primary Breast Sarcoma.The impact of dependent coverage expansion under the Affordable Care Act on time to breast cancer treatment among young women.Can we assess Cancer Waiting Time targets with cancer survival? A population-based study of individually linked data from the National Cancer Waiting Times monitoring dataset in England, 2009-2013 Timing and Delays in Breast Cancer Evaluation and Treatment What can the National Cancer Database tell us about disparities in advanced bladder cancer outcomes?

P2860

Q33595402-4A407381-6FAC-4CDC-86BA-558DA416D149 Q33765536-F2F76D97-4CBF-4162-AE35-967207F27FBC Q33829630-316B4DCD-901D-4569-989F-85017FAC0A31 Q36238866-05A41C82-09F3-4E81-96AE-8B554423BE2D Q37688653-1CAB295E-A3D5-43D2-BFFD-68425306527E Q38739664-5D3762DF-045B-4B46-8D6F-E55B9B4224E8 Q38750153-53E453C1-32B8-4EEE-A651-EC8232F9602D Q38820737-39166B6E-15FD-400C-9C44-24C591BAACD4 Q39339096-C90906B2-10ED-4510-9B92-38FA7E314D18 Q39438238-516BAF9A-59DD-4586-A108-38CD57FE1AD6 Q39509930-71DF6072-E399-45F6-9397-99E8C3A2CA58 Q39597075-B8343E74-EF2C-442E-8FB6-0D2C3EFF667D Q39656542-38FD93C8-C1AA-470D-BE51-3D7F461DE0D9 Q39680570-1BE87358-91FC-4713-9603-D322E7066F87 Q40263701-5EFABF13-AD24-414E-ABD7-0A7CF281D9B2 Q40576788-54EB94D8-64AB-4181-BBB9-16920DDF1B2A Q42323665-A6AECF77-EAC0-4506-9643-427CD2683688 Q42492498-5CA3B6A3-1F48-424E-A853-A753C5DD4A36 Q45254809-B25DFB5B-6AFF-45BA-A93B-00080E4E829F Q46302428-B9F9C89E-75B0-4719-8551-B64266E9ECB2 Q48148913-5D2C1D75-F3D9-4EF1-BB1A-0185E25C5BCA Q48332691-41DB2896-357E-4233-B45B-A30420877618 Q48364755-8BBA8E89-39A9-4756-9204-E45169B4C805 Q49923472-37C3479C-96DB-4726-B96B-4E1F589A3F6E Q50062662-51878FED-31F6-4C79-A28D-C2CC2D35A30B Q50513967-7AA8E8DB-2CFE-40E0-ADE0-36C0FB595A04 Q52564351-368F51F6-0C94-4878-9393-FEDF688DA06A Q52681585-B8197E8E-AD4C-4E5E-BD2F-BE7AD448089C Q53827930-2184E382-53AE-4C70-8832-DACB64E2A669 Q55042783-63C62304-50C7-4DE7-B2F1-984032DDEA9B Q55317100-56178D9B-2CEA-482B-883D-F3E60F6C43ED Q56341850-BC3E07E3-687E-44EA-8D18-7B72F0F10E4F Q57105011-840C267C-3BEC-4578-8516-4EEFEA0833E4 Q58804626-13F26424-9E4C-4A85-BF06-A5F536188573

P2860

Time to Surgery and Breast Cancer Survival in the United States.

http://www.wikidata.org/entity/Q36678065

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Time to Surgery and Breast Cancer Survival in the United States.

@ast

Time to Surgery and Breast Cancer Survival in the United States.

@en

type

label

Time to Surgery and Breast Cancer Survival in the United States.

@ast

Time to Surgery and Breast Cancer Survival in the United States.

@en

prefLabel

Time to Surgery and Breast Cancer Survival in the United States.

@ast

Time to Surgery and Breast Cancer Survival in the United States.

@en

P1433

Q36678065-01111EF6-A9D6-4A89-B3D3-E1BD79252CFC

P1476

Q36678065-1DE786FD-393B-45F6-BD89-F96E784F0EA6

P2093

Q36678065-43E444B4-8AAD-4CA4-B319-1859C6378B08

Q36678065-4EC8B29A-CCB9-42C6-99B5-C5AEC97CDDC2

Q36678065-52F40830-F822-41C5-B631-449E36D55505

Q36678065-66A7C45A-4DF5-4A7C-AAF7-CB1CA0A91092

Q36678065-9FFDF9CC-ACA2-4ABD-A6A5-E48680D03580

Q36678065-A67E6EAA-0FAD-45BE-A948-0B8A239BE568

Q36678065-C3C35D6D-91A1-4CB7-99EC-61334C5FDF63

Q36678065-CA205C29-F3DD-4F90-8176-7DFD5BEC014F

Q36678065-D3305B59-7C93-41E0-A52A-4810D0269E9B

Q36678065-E094C706-8328-4605-B685-544AE7ADE97B

P2860

Q36678065-08263FDA-40AD-495E-AD74-A4E5E4A5E3F4

Q36678065-091C3BA7-E2A5-491B-9A3B-C90F8627374C

Q36678065-2AB5F2C3-86B9-4341-9ABD-9B9017CCC1F4

Q36678065-2AEE0FE7-A9DC-4CDD-9F7F-F184A2D1990F

Q36678065-339E661A-C306-41CF-9E14-639B5B5B6C2C

Q36678065-42FC7445-BB93-4DCD-BA30-FCCE9C7FE2F8

Q36678065-54903D9A-F136-4EA8-A8C7-596C656FE807

Q36678065-6AC2A2D4-FF78-4C68-9579-BB860BFF0790

Q36678065-6FFA4CF5-CE8F-4296-9FFE-9F7913F3A15E

Q36678065-87497B72-750F-495D-873E-8E6DC542136A

P304

Q36678065-2CD81766-680E-4B36-A6C8-CC950C3398D1

P31

Q36678065-65709A77-8DB0-410E-85AD-D76FE2111E47

P356

Q36678065-BE2F5C0D-C766-41DC-87C5-54A36CB39DB2

P433

Q36678065-8C3FA0B6-9FBE-4582-BB97-7033BE6FED45

P478

Q36678065-2D5DDFFF-5B40-4651-9321-EAE59237D7C7

P50

Q36678065-9E7A15BE-B866-47F3-A4E2-AE2C55FBC531

P577

Q36678065-780722FA-B24A-4ECB-AA0F-819E220090D3

P698

Q36678065-F865852F-AA49-4B28-8C28-519BD14773CF

P932

Q36678065-99AD32AB-ABFF-4846-90C3-4C1D265EA0F8

P356

JAMAONCOL.2015.4508

P1433

P1476

Time to Surgery and Breast Cancer Survival in the United States

@en

P2093

Elin R Sigurdson

http://www.w3.org/2001/XMLSchema#string

Eric I Chang

http://www.w3.org/2001/XMLSchema#string

Eric Ross

http://www.w3.org/2001/XMLSchema#string

J Robert Beck

http://www.w3.org/2001/XMLSchema#string

Karen Ruth

http://www.w3.org/2001/XMLSchema#string

Marcia Boraas

http://www.w3.org/2001/XMLSchema#string

Neal S Topham

http://www.w3.org/2001/XMLSchema#string

Richard J Bleicher

http://www.w3.org/2001/XMLSchema#string

Sameer A Patel

http://www.w3.org/2001/XMLSchema#string

Yu-Ning Wong

http://www.w3.org/2001/XMLSchema#string

P2860

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Marginal structural models and causal inference in epidemiology

Comparison of cases captured in the national cancer data base with those in population-based central cancer registries.

Comorbidity measures for use with administrative data.

Influence of delay on survival in patients with breast cancer: a systematic review.

I. The Results of Radical Operations for the Cure of Carcinoma of the Breast.

Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study.

Preoperative delays in the US Medicare population with breast cancer.

Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer

Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial

P304

330-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1001/JAMAONCOL.2015.4508

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Brian L Egleston

P577

2016-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26659430

http://www.w3.org/2001/XMLSchema#string

P932

4788555

http://www.w3.org/2001/XMLSchema#string